ipriflavone has been researched along with Female Genital Diseases in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pellicano, M | 1 |
| Morgera, R | 1 |
| Affinito, P | 1 |
| Di Carlo, C | 1 |
| Napolitano, V | 1 |
| Merlino, P | 1 |
| Tremolaterra, F | 1 |
| Palomba, S | 1 |
| Nappi, C | 1 |
1 trial available for ipriflavone and Female Genital Diseases
| Article | Year |
|---|---|
[Effects of ipriflavone on bone loss induced by GnRH analog].
Topics: Analgesics; Antineoplastic Agents, Hormonal; Bone Remodeling; Female; Genital Diseases, Female; Geni | 1996 |